ABIGAIL MITROFF: Open Payments
NPI 1457871816 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 39 payments from 17 companies in 2025. Trend: 2023 $1,703 · 2024 $1,488 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $136 |
| Regeneron Healthcare Solutions, Inc. | 4 | $119 |
| Lilly USA, LLC | 4 | $96 |
| Janssen Biotech, Inc. | 4 | $84 |
| GENZYME CORPORATION | 2 | $69 |
| UCB, Inc. | 3 | $65 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| PFIZER INC. | 2 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $29 |
Products named: DUPIXENT, TALTZ, SKYRIZI, TREMFYA, Bimzelx, JUBLIA, RINVOQ, IQIRVO.
Industry payments across AZ — which companies pay providers there.
